Both in Pharmaceuticals
Dyne Therapeutics vs Parabilis Medicines
Over the past year DYN returned −6.8% and PBLS returned −27.5%; their daily moves had a correlation of 0.55.
DYN −6.8% PBLS −27.5%Growth of $1, one year, split-adjusted
| Metric | DYN | PBLS |
|---|---|---|
| Price | $16.98 | $26.75 |
| Market cap | $3.17B | $3.30B |
| Today | +0.21% | +0.91% |
| 1 month | +4.7% | −16.2% |
| 6 months | −2.5% | — |
| Year to date | −13.2% | — |
| 1 year | −29.8% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | −45239.9% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $685.0M | $1.11B |
| Dividend yield | — | — |
| Volatility (60d) | 58.2% | — |
| Short % of float | 14.6% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).